Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN955342 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) (AA 76-106), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 76-106, N-Term
- Vial size
- 0.4 mL
- Storage
- Store at 2 - 8°C for up to six months or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic adenocarcinoma.
Contribution of the S5-pore-S6 domain to the gating characteristics of the cation channels TRPM2 and TRPM8.
TRP channels in human prostate.
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic adenocarcinoma.
Yee NS, Zhou W, Lee M
Cancer letters 2010 Nov 1;297(1):49-55
Cancer letters 2010 Nov 1;297(1):49-55
Contribution of the S5-pore-S6 domain to the gating characteristics of the cation channels TRPM2 and TRPM8.
Kühn FJ, Witschas K, Kühn C, Lückhoff A
The Journal of biological chemistry 2010 Aug 27;285(35):26806-14
The Journal of biological chemistry 2010 Aug 27;285(35):26806-14
TRP channels in human prostate.
Van Haute C, De Ridder D, Nilius B
TheScientificWorldJournal 2010 Aug 17;10:1597-611
TheScientificWorldJournal 2010 Aug 17;10:1597-611
PSA reduces prostate cancer cell motility by stimulating TRPM8 activity and plasma membrane expression.
Gkika D, Flourakis M, Lemonnier L, Prevarskaya N
Oncogene 2010 Aug 12;29(32):4611-6
Oncogene 2010 Aug 12;29(32):4611-6
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC